Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 50 of 331 from CROI 2016
Workshop Convener
John W. Mellors
University of Pittsburgh, Pittsburgh, PA, United States
from CROI 2016 on February 22, 2016 9:00 AM-12:30 PM
Molecular Virology: Advances in the Understanding of HIV
Wesley I. Sundquist
University of Utah School of Medicine, Salt Lake City, UT, United States
from CROI 2016 on February 22, 2016 9:00 AM-12:30 PM
Immunology and Vaccines
Richard A. Koup
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
from CROI 2016 on February 22, 2016 9:00 AM-12:30 PM
The HIV Latent Reservoir: Obstacles and Strategies to a Cure
Huldrych F. Günthard
University Hospital Zurich, Zurich, Switzerland
from CROI 2016 on February 22, 2016 9:00 AM-12:30 PM
The Rapidly Changing Landscape of HIV Prevention
Sharon L. Hillier
Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA, United States
from CROI 2016 on February 22, 2016 9:00 AM-12:30 PM
Unraveling the Complexities of Long Term Complications of Treated HIV Infection
Judith S. Currier
David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, United States
from CROI 2016 on February 22, 2016 9:00 AM-12:30 PM
Martin Delaney Presentation: Stigma, Trauma, and Stress
Introduction
Steven F. Wakefield
HIV Vaccine Trials Network, Fred Hutchinson Cancer, Research Center, Seattle, WA, United States
Panel Discussion on Stigma, Trauma, and Stress: Considerations for HIV Research and Programs
Morenike Ukpong-Folayan
Obafemi Awolowo University, Ile-Ife, Nigeria
Limits and Complexity Research on Stigma and HIV
Laurel Sprague
The Sero Project, Milford, PA, United States
Women's Rights and Decision Making in Hormonal Contraception
Sethembiso Mthembu
International Community of Women Living with HIV, Southern Africa, Durban, South Africa
Engaging Young Men of Color in Community HIV Prevention Studies
Keith Green
Univ of Chicago, School of Social Service Administration , Chicago, IL, United States
Questions and Answers
from CROI 2016 on February 22, 2016 1:00 PM-2:00 PM
Welcome and Overview of CROI 2016
Julie M. Overbaugh
CROI Chair and Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Susan P. Buchbinder
CROI Vice Chair and University of California, San Francisco, CA, United States
Judith Currier
CROI Vice Chair and University of California, Los Angeles, CA, United States
from CROI 2016 on February 22, 2016 2:00 PM-3:00 PM
Discussion of Special Session – Ebola: One Year Later
Chair
Kevin M. De Cock
CDC, Nairobi, Kenya
SS - EBOLA: Sequelae of Ebola Virus Disease in Surviving Patients in Guinea: Postebogui Cohort
Eric Delaporte
UMI 233-IRD/U1175-INSERM/Montpellier University, Montpellier, France
SS - EBOLA: Dynamics of Ebola Virus Clearance in Semen in Guinea
Daouda Sissoko
INSERM U897, Bordeaux, France
from CROI 2016 on February 22, 2016 2:00 PM-3:00 PM
Discussion of Oral Abstract Session 9 – Expanding the Toolbox for Prevention
Chair
Wafaa El-Sadr
ICAP at Columbia University, New York, NY, United States
OA9: A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women
Jared M. Baeten
University of Washington, Seattle, WA, United States
OA9: Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women
Annalene Nel
International Partnership for Microbicides, Paarl, South Africa
from CROI 2016 on February 22, 2016 2:00 PM-3:00 PM
Workshop Convener
Richard E. Chaisson
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Key Considerations in Studies of Antiviral Pharmacokinetics and Pharmacodynamics
Jennifer J. Kiser
University of Colorado, Denver, CO, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Using Big Data to Improve the HIV Care and Prevention Continuum
Patrick Sullivan
Emory University, Atlanta, GA, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
HIV Transmission Networks and HIV Prevention in the Era of TasP and PrEP
Martina Morris
University of Washington, Seattle, WA, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Deciphering Mucosal Barrier Functionality and HIV Immunity by Mass Spectrometry
Adam Burgener
University of Manitoba, Winnipeg, MB, Canada
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Drop-Based Microfluidics for Single-Cell Studies
David A. Weitz
Harvard University, Boston, MA, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Integration of Systems Biology with Tissue Engineering and Organs-On-Chips
Linda Griffith
Massachusetts Institute of Technology, Boston, MA, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Treatment for HCV Genotype 1-Infected Patients With HIV/HCV Coinfection
Anne F. Luetkemeyer
University of California San Francisco, San Francisco, CA, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
HCV Genotype 3 Infection: Treatment for Patients With Cirrhosis and Treatment Failure
Karine LaCombe
Sorbonne Universités, Paris, France
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
HCV Infection Treatment Before and After Liver Transplant
Elizabeth C. Verna
Columbia University, New York, NY, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Treatment of HCV Infection in Groups at High Risk for Reinfection
Oluwaseun Falade-Nwulia
Johns Hopkins University, Baltimore, MD, United States
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Questions and Answers
from CROI 2016 on February 22, 2016 2:15 PM-4:00 PM
Opening Session Host
Julie M. Overbaugh
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from CROI 2016 on February 22, 2016 5:00 PM-7:00 PM
Bernard Fields Lecture: T Cell Control of HIV: Implications for Vaccines and Cure
Bruce D. Walker
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from CROI 2016 on February 22, 2016 5:00 PM-7:00 PM
N'Galy-Mann Lecture: Confronting HIV and TB From the Bronx, NY, to Tugela Ferry, South Africa   
Gerald H. Friedland
Yale University School of Medicine, New Haven, CT, United States
from CROI 2016 on February 22, 2016 5:00 PM-7:00 PM
Fighting AIDS With Style
Kenneth Cole
Kenneth Cole Productions, Inc, and Chairman of the Board of amfAR, United States
from CROI 2016 on February 22, 2016 5:00 PM-7:00 PM
Harnessing Antibodies for HIV-1 Prevention and Treatment
John R. Mascola
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
from CROI 2016 on February 23, 2016 8:30 AM-9:00 AM
Antiretroviral Therapy: Where Are We Now? Where Are We Going?
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from CROI 2016 on February 23, 2016 9:00 AM-9:30 AM
Early Antiretroviral Therapy Does Not Improve Vascular Function: A START Substudy
Jason V. Baker
Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Comparing Cardiovascular Disease Risk Scores for Use in HIV-Infected Individuals
Heidi M. Crane
University of Washington, Seattle, WA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Stroke Incidence Highest in Women and Black HIV-Infected Participants in ALLRT Cohort
Felicia Chow
University of California San Francisco, San Francisco, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Aspirin Fails to Impact Immune Activation or Endothelial Function in Treated HIV
Meagan K. O'Brien
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Body Composition Changes on DRV/r + either RAL or TDF/FTC As First-Line ART
Jose I. Bernardino
Institute for Health Research of La Paz University Hospital, Madrid, Spain
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Antiretrovirals, Fractures, and Osteonecrosis in a Large European HIV Cohort
Alvaro H.D. Borges
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
A Single Dose Zoledronic Acid Prevents Antiretroviral-Induced Bone Loss
Ighovwerha Ofotokun
Emory University School of Medicine, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Recovery of Bone Mineral Density After Stopping Oral HIV Preexposure Prophylaxis
Robert Grant
University of California San Francisco, San Francisco, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Breast Milk and In Utero HIV-1 Transmission Select for Unique Envelope Signatures
Nicholas E. Webb
University of California Los Angeles, Los Angeles, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial
Elaine J. Abrams
ICAP, Columbia University Mailman School of Public Health, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
National HIV Transmission in 4-12 Week Olds in Malawi's PMTCT Option B+ Program
Sundeep K. Gupta
Centers for Disease Control and Prevention, Lilongwe, Malawi
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral
George K. Siberry
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children
Roger L. Shapiro
Harvard School of Public Health, Boston, MA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Urgent Versus Post-Stabilization ART in Hospitalized Children: A Randomized Trial
Lisa M. Cranmer
Emory University School of Medicine, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Three-Year Outcomes in PMTCT-Exposed Children Switched to EFV Once Suppressed on LPVr
Pamela Murnane
Columbia University, Johannesburg, South Africa
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Efavirenz Is Associated With Higher Bone Mass in South African Children With HIV
Stephen M. Arpadi
Columbia University Medical Center, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Rare Host Genetic Variation Influencing Risk of Heterosexual HIV-1 Acquisition
Romel D. Mackelprang
University of Washington, Seattle, WA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
HIV-1 Laboratory Contagion During Recombination Procedures With Defective Constructs
Claudia Alteri
University of Rome Tor Vergata, Rome, Italy
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Identification of a Highly Functional DC Subset in Controllers by Single-Cell RNA-Seq
Enrique Martin-Gayo
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
The Sooty Mangabey Genome Sequence Reveals New Insights in Natural SIV Infections
David J. Palesch
Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Hyperacute Microbial Translocation During Pathogenic SIV Infection
Adam J. Ericsen
University of Wisconsin-Madison, Madison, WI, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
CD8 T Cells Are Required to Suppress Viremia in SIV-Infected ART Treated Macaques
Emily K. Cartwright
Emory University, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 50 of 331 from CROI 2016